Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A specific, sensitive and high-capacity immunoassay for PAF.

B A Baldo1, M A Smal, A C McCaskill

  • 1Kolling Institute of Medical Research, Royal North Shore Hospital of Sydney, St. Leonards, N.S.W., Australia.

Lipids
|December 1, 1991
PubMed
Summary

A new radioimmunoassay accurately measures platelet-activating factor (PAF) in low concentrations. This method is specific, distinguishing PAF from similar lipids, aiding research into its biological roles.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sugammadex and hypersensitivity.

Anaesthesia and intensive care·2014
Same author

Sugammadex and anaphylaxis in the operating theater.

Revista espanola de anestesiologia y reanimacion·2014
Same author

Cross-reactive antigens for natural IgE antibodies: allergens with the potential to transform a dormant to an active allergic response?

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2012
Same author

The cyclodextrin sugammadex and anaphylaxis to rocuronium: is rocuronium still potentially allergenic in the inclusion complex form?

Mini reviews in medicinal chemistry·2012
Same author

Histamine-releasing and allergenic properties of opioid analgesic drugs: resolving the two.

Anaesthesia and intensive care·2012
Same author

Drug-specific cyclodextrins with emphasis on sugammadex, the neuromuscular blocker rocuronium and perioperative anaphylaxis: implications for drug allergy.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2011

Area of Science:

  • Biochemistry
  • Immunology
  • Analytical Chemistry

Background:

  • Platelet-activating factor (PAF) is a potent lipid mediator involved in various physiological and pathological processes.
  • Accurate quantification of PAF is crucial for understanding its role in inflammation, allergy, and thrombosis.
  • Existing methods for PAF detection may lack specificity or sensitivity.

Purpose of the Study:

  • To develop and validate a specific and sensitive radioimmunoassay for the quantitative determination of platelet-activating factor (PAF).
  • To assess the specificity of the developed assay against related lipid compounds.

Main Methods:

  • Development of a radioimmunoassay utilizing specific antibodies against PAF.
  • Quantitative hapten inhibition studies were performed to determine assay specificity.

Related Experiment Videos

  • Assay sensitivity was evaluated across a defined concentration range.

    • Main Results:

    • The developed radioimmunoassay demonstrated high sensitivity, quantifying PAF in the range of 10-1000 pg (0.02-2 pmoles).
    • Hapten inhibition studies confirmed specificity for the C-2 acetyl group and C-1 ether linkage of PAF.
    • No significant cross-reactivity was observed with lysophosphatidylcholine, phosphatidylcholine, or lysoPAF.

    Conclusions:

    • A highly specific and sensitive radioimmunoassay for PAF has been successfully developed.
    • This assay provides a reliable tool for measuring PAF levels in biological samples.
    • The specificity profile aids in distinguishing PAF from structurally similar phospholipids.